Patrick Rossignol
Impact in
-
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
Papers in
-
- Heart Failure Treatment and Management 113
- Blood Pressure and Hypertension Studies 46
- Cardiac Fibrosis and Remodeling 24
- Cardiovascular Function and Risk Factors 17
- Nephrology 53
- Chronic Kidney Disease and Diabetes 20
- Dialysis and Renal Disease Management 19
- Co-authors
- Faiez M. Zannad (251 shared papers)Bertram Pitt (90 shared papers)Nicolas Girerd (173 shared papers)João Pedro Ferreira (124 shared papers)Natalia López‐Andrés (34 shared papers)Renaud Fay (34 shared papers)Scott David Solomon (22 shared papers)John J.V. McMurray (38 shared papers)
- Journals
- European Journal of Heart Failure (59 papers)Journal of Hypertension (26 papers)Clinical Research in Cardiology (23 papers)Hypertension (22 papers)Nephrology Dialysis Transplantation (19 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Patrick Rossignol
598 papers receiving 26.4k citations
Patrick Rossignol's Hit Papers
Peers
Comparison fields: 5 of 148
- Cardiology and Cardiovascular Medicine 8.3k
- Nephrology 2.4k
- Critical Care and Intensive Care Medicine 565
- Infectious Diseases 1.8k
- Pulmonary and Respiratory Medicine 2.4k
Countries citing papers authored by Patrick Rossignol
This map shows the geographic impact of Patrick Rossignol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Rossignol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Rossignol more than expected).
Fields of papers citing papers by Patrick Rossignol
This network shows the impact of papers produced by Patrick Rossignol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Rossignol. The network helps show where Patrick Rossignol may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Rossignol, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 619 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Autoantibodies against type I IFNs in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 2107 |
| 2 | Inborn errors of type I IFN immunity in patients with life-threatening COVID-19 Hit paper breakdown → | 2020 | 1757 |
| 3 | The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology Hit paper breakdown → | 2019 | 796 |
| 4 | Chronic Kidney Disease and Coronary Artery Disease Hit paper breakdown → | 2019 | 512 |
| 5 | The systemic nature of CKD Hit paper breakdown → | 2017 | 368 |
| 6 | 2014 | 362 | |
| 7 | Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Hit paper breakdown → | 2019 | 348 |
| 8 | Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference Hit paper breakdown → | 2019 | 347 |
| 9 | 2018 | 342 | |
| 10 | 2012 | 309 | |
| 11 | Evaluation of Kidney Function Throughout the Heart Failure Trajectory – A Position Statement from the Heart Failure Association of the European Society of Cardiology Hit paper breakdown → | 2020 | 300 |
| 12 | 2002 | 276 | |
| 13 | 2019 | 274 | |
| 14 | 2018 | 272 | |
| 15 | Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial Hit paper breakdown → | 2019 | 269 |
| 16 | 2012 | 243 | |
| 17 | 2015 | 233 | |
| 18 | 2013 | 231 | |
| 19 | 2018 | 231 | |
| 20 | 2013 | 223 |
About Patrick Rossignol
Patrick Rossignol is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Critical Care and Intensive Care Medicine, having authored 619 papers that have together received 27.2k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (113 papers), Potassium and Related Disorders (46 papers), Blood Pressure and Hypertension Studies (46 papers), Cardiac Fibrosis and Remodeling (24 papers), Chronic Kidney Disease and Diabetes (20 papers), Dialysis and Renal Disease Management (19 papers), Hormonal Regulation and Hypertension (17 papers) and Cardiovascular Function and Risk Factors (17 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (8.3k citations), Nephrology (2.4k citations), Critical Care and Intensive Care Medicine (565 citations), Infectious Diseases (1.8k citations) and Pulmonary and Respiratory Medicine (2.4k citations). Patrick Rossignol has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Faiez M. Zannad, Bertram Pitt, Nicolas Girerd, João Pedro Ferreira, Natalia López‐Andrés, Renaud Fay, Scott David Solomon, John J.V. McMurray, Ernesto Martínez‐Martínez and Jean‐Baptiste Michel. Their work appears in journals such as European Journal of Heart Failure, Journal of Hypertension, Clinical Research in Cardiology, Hypertension and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.